Volume | 48,445 |
|
|||||
News | - | ||||||
Day High | 17.20 | Low High |
|||||
Day Low | 16.97 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Indivior PLC | INDV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
17.18 | 16.97 | 17.20 | 16.97 | 17.34 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
936 | 48,445 | US$ 17.10 | US$ 828,618 | - | 14.3809 - 26.50 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:07 | formt | 296 | US$ 16.97 | USD |
Indivior PLC Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.83B | 135.27M | - | 1.09B | 2M | 0.01 | 912.16 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Indivior News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INDV Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 18.02 | 18.13 | 16.97 | 17.62 | 74,569 | -1.05 | -5.83% |
1 Month | 18.65 | 19.13 | 16.97 | 17.81 | 104,865 | -1.68 | -9.01% |
3 Months | 21.29 | 23.22 | 16.97 | 20.27 | 126,756 | -4.32 | -20.29% |
6 Months | 16.71 | 23.22 | 14.3809 | 19.09 | 97,836 | 0.26 | 1.56% |
1 Year | 26.50 | 26.50 | 14.3809 | 19.39 | 58,099 | -9.53 | -35.96% |
3 Years | 26.50 | 26.50 | 14.3809 | 19.39 | 58,099 | -9.53 | -35.96% |
5 Years | 26.50 | 26.50 | 14.3809 | 19.39 | 58,099 | -9.53 | -35.96% |
Indivior Description
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. |